Diabetes Care, Vol 15, Issue 9 1181-1191, Copyright © 1992 by American Diabetes Association

ARTICLES

Microalbuminuria. Implications for micro- and macrovascular disease

T Deckert, A Kofoed-Enevoldsen, K Norgaard, K Borch-Johnsen, B Feldt-Rasmussen and T Jensen
Steno Diabetes Center, Gentofte, Denmark.

Microalbuminuria is diagnosed when the UAER is greater than 20 but less than 200 micrograms/min. The prevalence of microalbuminuria among diabetic patients is 15-20%. Persistent microalbuminuria in diabetic patients is a risk marker not only of renal disease, but also of proliferative retinopathy and cardiovascular morbidity and mortality. Even among nondiabetic individuals, those with microalbuminuria tend to have an increased cardiovascular morbidity. The established cardiovascular risk factors, such as smoking, elevated plasma cholesterol, fibrinogen, and hypertension, are seen more frequently in diabetic patients with persistent microalbuminuria than in normoalbuminuric diabetic patients of similar age, sex, and diabetes duration. However, these risk factors cannot by themselves explain the cardiovascular overmortality in these patients. In addition, insulin resistance or genetic disposition to hypertension or cardiovascular disease fails to be the missing link. Accumulating evidence suggests a common pathogenetic mechanism for microalbuminuria and premature atherosclerosis (i.e., qualitative alterations of the extracellular matrix, including decreased density and sulfation of HS-PG). Decreased density of HS in the glomeruli may lead to albuminuria and mesangial proliferation. In the intima of large vessel walls, decreased density and/or sulfation of HS may enhance several of the processes involved in premature atherosclerosis. Diabetes affects the composition and structure of the extracellular matrix in many ways and leads to decreased density and sulfation of HS-PG by several mechanisms. Genetic differences in the sulfation of HS and/or genetic defects in the coordinated biosynthesis of HS-PG might contribute to decreased concentration and sulfation of HS-PG in susceptible individuals. It is hoped that susceptibility genes can be identified soon, thereby making prevention of severe late diabetic complications more successful.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. Y. Kim, A. S. Astrup, M. Stuber, L. Tarnow, E. Falk, R. M. Botnar, C. Simonsen, L. Pietraszek, P. R. Hansen, W. J. Manning, et al. Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes With and Without Diabetic Nephropathy Circulation, January 16, 2007; 115(2): 228 - 235. [Abstract] [Full Text] [PDF]

				P. Tessari, A. Coracina, E. Kiwanuka, M. Vedovato, M. Vettore, A. Valerio, M. Zaramella, and G. Garibotto Effects of Insulin on Methionine and Homocysteine Kinetics in Type 2 Diabetes With Nephropathy Diabetes, October 1, 2005; 54(10): 2968 - 2976. [Abstract] [Full Text] [PDF]

				V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]

				M. Svensson, G. Sundkvist, H. J. Arnqvist, E. Bjork, G. Blohme, J. Bolinder, M. Henricsson, L. Nystrom, O. Torffvit, I. Waernbaum, et al. Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS) Diabetes Care, October 1, 2003; 26(10): 2903 - 2909. [Abstract] [Full Text] [PDF]

				H. L. Hillege, V. Fidler, G. F.H. Diercks, W. H. van Gilst, D. de Zeeuw, D. J. van Veldhuisen, R. O.B. Gans, W. M.T. Janssen, D. E. Grobbee, P. E. de Jong, et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population Circulation, October 1, 2002; 106(14): 1777 - 1782. [Abstract] [Full Text] [PDF]

				G. Heper, T. Durmaz, S. Namik Murat, and E. Ornek Clinical and Angiographic Outcomes of Diabetic Patients After Coronary Stenting: A Comparison of Native Vessel Stent Restenosis Rates in Different Diabetic Subgroups Angiology, May 1, 2002; 53(3): 287 - 295. [Abstract] [PDF]

				C. Yorgancioglu, H. Tokmakoglu, K. Suzer, and Y. Zorlutuna Does microalbuminuria in diabetic patients affect the postoperative course after coronary artery bypass surgery? Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 395 - 400. [Abstract] [Full Text] [PDF]

				J. P Garg and G. L Bakris Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vascular Medicine, February 1, 2002; 7(1): 35 - 43. [Abstract] [PDF]

				U. Weis, B. Turner, J. Gibney, G.F. Watts, V. Burke, K.M. Shaw, and M.H. Cummings Long-term predictors of coronary artery disease and mortality in type 1 diabetes QJM, November 1, 2001; 94(11): 623 - 630. [Abstract] [Full Text] [PDF]

				J. Christopher, V. Velarde, D. Zhang, D. Mayfield, R. K. Mayfield, and A. A. Jaffa Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1537 - H1546. [Abstract] [Full Text] [PDF]

				T H M Moore and J P H Shield Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study Arch. Dis. Child., September 1, 2000; 83(3): 239 - 243. [Abstract] [Full Text] [PDF]

				R. Pedrinelli, G. Penno, G. Dell'Omo, S. Bandinelli, D. Giorgi, V. Di Bello, M. Nannipieri, R. Navalesi, and M. Mariani Transvascular and Urinary Leakage of Albumin in Atherosclerotic and Hypertensive Men Hypertension, August 1, 1998; 32(2): 318 - 323. [Abstract] [Full Text] [PDF]

				S. Makimattila, A. Virkamaki, P.-H. Groop, J. Cockcroft, T. Utriainen, J. Fagerudd, and H. Yki-Jarvinen Chronic Hyperglycemia Impairs Endothelial Function and Insulin Sensitivity Via Different Mechanisms in Insulin-Dependent Diabetes Mellitus Circulation, September 15, 1996; 94(6): 1276 - 1282. [Abstract] [Full Text]